Lilly To Buy Alnara And Its Non-Porcine Pancreatic Enzyme Replacement Therapy

Alnara hopes to leverage Lilly's prior success with recombinant insulin products.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet